PPARγ
-
Pioglitazone hydrochloride
Pioglitazone hydrochloride is a selective PPARγ agonist (EC50 = 0.69 μM). Learn MoreStarting at: $45.00
-
nTZDpa
nTZDpa is a potent, selective non-thiazolidinedione PPARγ partial agonist (EC50 = 57 nM); produces ~25% maximum efficacy. Learn MoreStarting at: $100.00
-
GW 1929 hydrochloride
GW 1929 hydrochloride is a highly selective orally active peroxisome proliferator-activated receptor (PPAR)γ agonist (pEC50 values are 8.05, < 4 and < 4 for human PPARγ, PPARα and PPARδ receptors respectively). Learn MoreStarting at: $135.00
-
S26948
S26948 is a selective PPARγ agonist (EC50 = 8.83 nM), which drives normal adipocyte differentiation and exhibits a lipid-lowering effect; reduces atherosclerosis in E2-KI mice, and displays antidiabetic properties and improves hepatic insulin sensitivity in intralipid-infusion (IL) rats. Learn MoreStarting at: $139.00
-
BADGE
RS 39604 hydrochloride is a potent and selective 5-HT4 antagonist, with a pKi of 9.1 at 5-HT4 receptors in guinea pig striatal membranes and greater than 1000-fold selectivity over 5-HT1A, 2C, 3 and D1, D2, M1, M2, AT1, B1 and α1C receptors. Learn MoreStarting at: $80.00
-
Ciglitazone
Ciglitazone is a selective agonist at PPAR&gamma with an EC50 value of 3 μM in vivo. Learn MoreStarting at: $139.00
-
SR 202
SR 202 is a selective PPARγ antagonist that inhibits PPARγ-dependent adipocyte differentiation and growth in vitro and in vivo. Learn MoreStarting at: $90.00